TREA

97594404 - AFFIMED

Follow

Information

  • Trademark
  • 97594404
  • Serial Number
    97594404
  • Registration Number
    7283748
  • Filing Date
    September 16, 2022
    3 years ago
  • Registration Date
    January 23, 2024
    2 years ago
  • Transaction Date
    January 23, 2024
    2 years ago
  • Status Date
    January 23, 2024
    2 years ago
  • Published for Opposition Date
    November 07, 2023
    2 years ago
  • Location Date
    January 23, 2024
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GAYNOR, BARBARA ANNE
  • Attorney Docket Number
    8167-004T
    Attorney Name
    Shauna M. Wertheim
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
AFFIMED
Case File Statements
  • DM0000: The mark consists of the stylized term "AFFIMED" with the letters "AFFI" in teal and the letters "MED" in pink and with a stylized image of a cell inside of a teal single line circle to the left of the letter "A" and with two short teal lines extending from the lower right edge of the circle. The cell is colored in various shades of pink and in the interior of the cell is an oval colored in a dark shade of pink with a white outline. The remaining color white indicates transparent area and is not part of the mark.
  • GS0051: Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes, all used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations for medical or veterinary purposes and in the form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for medical or veterinary purposes and for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides, all used for treatment of cancer, treatment of tumours, and immunotherapy purposes; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays, all used for treatment of cancer, treatment of tumours, and immunotherapy purposes
  • PM0001: AFFI MED
  • CC0000: The color(s) teal, pink and white is/are claimed as a feature of the mark.
  • GS0011: Biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for scientific laboratory and scientific experimentation purposes, in particular for conducting experimental assays, all of the foregoing other than for medical or veterinary purposes
  • GS0421: Scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of immunotherapy, in particular in the field of immuno-oncology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of virology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design and engineering design, all in the field of antiinfectives; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research, and design in the nature of new product design, all in the field of neurodegenerative diseases; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial analysis and research services, namely, industrial research in the field of pharmaceuticals
Case File Event Statements
  • 1/23/2024 - 2 years ago
    20 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 1/23/2024 - 2 years ago
    19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/4/2024 - 2 years ago
    18 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/7/2023 - 2 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/7/2023 - 2 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/18/2023 - 2 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/6/2023 - 2 years ago
    14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/6/2023 - 2 years ago
    13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/6/2023 - 2 years ago
    12 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/2/2023 - 2 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/21/2023 - 2 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/20/2023 - 2 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/20/2023 - 2 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/3/2023 - 2 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/3/2023 - 2 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/3/2023 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/28/2023 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/4/2022 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/3/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/20/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP